InspireMD, Inc.
InspireMD, Inc., headquartered in Illinois, is a pioneering medical device company specialising in innovative solutions for the treatment of cardiovascular diseases. Founded in 2006, InspireMD has made significant strides in the industry, particularly with its proprietary MGuard™ technology, which combines a unique mesh design with a drug-eluting stent to enhance patient outcomes. With a focus on improving the safety and efficacy of vascular interventions, InspireMD operates primarily in North America and Europe, positioning itself as a leader in the interventional cardiology market. The company has achieved notable milestones, including successful clinical trials and regulatory approvals, solidifying its reputation for excellence in medical innovation. Through its commitment to advancing cardiovascular care, InspireMD continues to set itself apart with cutting-edge products that address critical patient needs.
DitchCarbon Score
How does InspireMD, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
InspireMD, Inc.'s score of 18 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
InspireMD, Inc.'s reported carbon emissions
InspireMD, Inc., headquartered in Illinois, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the company may still be engaged in industry-standard practices related to climate commitments, which could include evaluating their carbon footprint and exploring strategies for emissions reduction in the future. As the landscape of corporate responsibility evolves, InspireMD may consider aligning with recognised frameworks to enhance their environmental stewardship.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
InspireMD, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
